Cargando…
Molecular landscape and therapeutic alterations in Asian soft‐tissue sarcoma patients
BACKGROUND: Soft‐tissue sarcoma (STS) is a rare solid malignant tumor with numerous histologic subtypes. Current studies on targeted therapy for STS are in preclinical and early‐phase trials. Genomic differences largely influence the prognosis of patients even with the same subtype. To investigate t...
Autores principales: | Gan, Meifu, Zhang, Chen, Qiu, Liqing, Wang, Yue, Bao, Hua, Yu, Ruoying, Liu, Rui, Wu, Xue, Shao, Yang, Hou, Peifeng, Fei, Zhenglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636498/ https://www.ncbi.nlm.nih.gov/pubmed/35586877 http://dx.doi.org/10.1002/cam4.4725 |
Ejemplares similares
-
The proteomic landscape of soft tissue sarcomas
por: Burns, Jessica, et al.
Publicado: (2023) -
On the Relevance of Soft Tissue Sarcomas Metabolic Landscape Mapping
por: Esperança-Martins, Miguel, et al.
Publicado: (2022) -
Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma
por: Roszik, Jason, et al.
Publicado: (2021) -
Prognostic Implications of Six Altered Genes in Asian Non-Surgical Esophageal Carcinoma Patients Treated with Chemoradiotherapy
por: Feng, Alei, et al.
Publicado: (2022) -
The current management of alveolar soft part sarcomas
por: Chang, Xiaojing, et al.
Publicado: (2021)